From Casetext: Smarter Legal Research

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
Oct 10, 2003
MDL Docket No, 1290, Misc. No. 99ms276 (D.D.C. Oct. 10, 2003)

Opinion

MDL Docket No, 1290, Misc. No. 99ms276

October 10, 2003


ORDER


Pending before the Court is Defendants' Motion to Compel [# 320]. This motion invokes a great deal of history in this case, and is related to many other motions (e.g., Motion for Curative Notice to Certain Class Members; Class Plaintiffs' Motion for Protective Order) that raised nearly identical factual and legal issues but which are now moot as a result of the Direct Purchaser Final Settlement Approval of June 16, 2003.

Having fully considered the Motion to Compel, as well as the submissions of the parties and the subpoena recipients regarding the continued relevance of that motion, the Court finds under the liberal rules of discovery that the information sought by the Defendants is relevant, hi light of the procedural posture of this case, the Court need not delve into the concerns raised of alleged improper conduct related to the use of discovery. Any disputes as to the scope of this discovery can be resolved at the request of the parties by a Magistrate Judge.

Accordingly, it is hereby

ORDERED that the motion is GRANTED.

SO ORDERED.


Summaries of

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
Oct 10, 2003
MDL Docket No, 1290, Misc. No. 99ms276 (D.D.C. Oct. 10, 2003)
Case details for

In re Lorazepam Clorazepate Antitrust Litigation

Case Details

Full title:IN RE LORAZEPAM CLORAZEPATE ANTITRUST LITIGATION This Order applies to…

Court:United States District Court, D. Columbia

Date published: Oct 10, 2003

Citations

MDL Docket No, 1290, Misc. No. 99ms276 (D.D.C. Oct. 10, 2003)